全文获取类型
收费全文 | 814篇 |
免费 | 21篇 |
出版年
2023年 | 3篇 |
2021年 | 6篇 |
2019年 | 6篇 |
2018年 | 5篇 |
2017年 | 5篇 |
2016年 | 17篇 |
2015年 | 17篇 |
2014年 | 21篇 |
2013年 | 58篇 |
2012年 | 57篇 |
2011年 | 44篇 |
2010年 | 30篇 |
2009年 | 18篇 |
2008年 | 37篇 |
2007年 | 55篇 |
2006年 | 62篇 |
2005年 | 64篇 |
2004年 | 59篇 |
2003年 | 66篇 |
2002年 | 53篇 |
2001年 | 12篇 |
2000年 | 8篇 |
1999年 | 13篇 |
1998年 | 4篇 |
1997年 | 10篇 |
1996年 | 12篇 |
1995年 | 4篇 |
1994年 | 8篇 |
1993年 | 4篇 |
1992年 | 4篇 |
1991年 | 9篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 6篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 9篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 5篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有835条查询结果,搜索用时 15 毫秒
61.
The quality of pollen of tea (Camellia sinensis L.), big leaf podocarp tree [Podocarpus macrophyllus (Thumb.)] and sweet corn (Zea mays L.) as alternative food sources was evaluated for seven native phytoseiid mite species, Amblyseius eharai Amitai and Swirski, Euseius sojaensis (Ehara), Neoseiulus californicus (McGregor), Neoseiulus womersleyi (Schicha), Phytoseius nipponicus Ehara, Chanteius contiguus (Chant) and Typhlodromus vulgaris Ehara. Tea pollen was of high nutritional value for all seven phytoseiid species: most larvae developed to adults and most females oviposited well. Development and oviposition differed greatly among phytoseiid species when reared on big leaf podocarp tree pollen: A. eharai, T. vulgaris and C. contiguus could utilize the pollen as food, but the other phytoseiid species could not. In addition, big leaf podocarp tree pollen could be utilized by A. eharai as food for longer than the other pollen. The quality of sweet corn pollen was inferior in general, although it could somehow favor the development and oviposition of six phytoseiid species except for E. sojaensis. 相似文献
62.
Jürgen Geisler Takashi Suzuki Hildegunn Helle Yasuhiro Miki Shuji Nagasaki Nhat K. Duong Dagfinn Ekse Turid Aas Dean B. Evans Per E. Lønning Hironobu Sasano 《The Journal of steroid biochemistry and molecular biology》2010,118(4-5):237-241
Breast cancer tissue estrogen levels on an average exceed plasma as well as benign breast tissue levels. To evaluate the contribution of intra-tumor aromatization to individual tumor estrogen levels (estradiol, E2; estrone, E1; estrone sulfate, E1S), breast cancer tissue sections obtained during mastectomy in 28 postmenopausal breast cancer patients were stained for aromatase protein expression using the aromatase antibody 677. The findings were correlated to intra-tumor estrogen levels determined with a highly sensitive HPLC-RIA. Staining with 677 alone (irrespective of the hormone receptor status) revealed no difference in tumor E2 levels comparing 677+ versus 677? tumors, although a non-significant trend towards higher tumor E1 and E1S levels was observed in 677+ breast cancers. In contrast, tumor levels of E2 were significantly higher in ER+ tumors compared to ER? tumors (P < 0.001) and to benign breast tissue from the same breast (P < 0.001). Analysing the additional effect of positive staining with the aromatase antibody 677 on tumor estrogen levels in the subgroup of ER+ tumors, revealed significantly higher tumor levels of E2 (mean level of 544.7 versus 197.1 fmol/g tissue) as well as a non-significant trend concerning tumor E1 (mean level of 296.9 versus 102.1 fmol/g tissue). The mean tumor tissue E1S level was observed somewhat lower in ER+677+ (103.5 fmol/g) versus ER+677? tumors (190.1 fmol/g). In the subgroup of ER+PgR+ tumors, tissue levels of E2 were also found to be significantly higher among 677+ compared to 677? tumors: 873.2 fmol/g (95% CI 395.9–1925.6) versus 217.9 fmol/g (95% CI 88.8–534.9) (P = 0.015).In conclusion, our results indicate a moderate effect of aromatase enzyme expression evaluated by IHC using the antibody 677 on intra-tumor estrogen levels among ER+ breast cancers. A substantial interindividual variation in the ratios between the individual estrogen fractions suggests additional effects, like alterations in other enzymes to be involved in the intra-tumor estrogen homeostasis. 相似文献
63.
Ebi M Kataoka H Shimura T Kubota E Hirata Y Mizushima T Mizoshita T Tanaka M Mabuchi M Tsukamoto H Tanida S Kamiya T Higashiyama S Joh T 《Biochemical and biophysical research communications》2010,402(3):449-454
Background and aims: Transforming growth factor-beta (TGFβ) is known to potently inhibit cell growth. Loss of responsiveness to TGFβ inhibition on cell growth is a hallmark of many types of cancer, yet its mechanism is not fully understood. Membrane-anchored heparin-binding EGF-like growth factor (proHB-EGF) ectodomain is cleaved by a disintegrin and metalloproteinase (ADAM) members and is implicated in epidermal growth factor receptor (EGFR) transactivation. Recently, nuclear translocation of the C-terminal fragment (CTF) of pro-HB-EGF was found to induce cell growth. We investigated the association between TGFβ and HB-EGF signal transduction via ADAM activation.Materials and methods: The CCK-8 assay in two gastric cancer cell lines was used to determine the effect for cell growth by TGFβ. The effect of two ADAM inhibitors was also evaluated. Induction of EGFR phosphorylation by TGFβ was analyzed and the effect of the ADAM inhibitors was also examined. Nuclear translocation of HB-EGF-CTF by shedding through ADAM activated by TGFβ was also analyzed. EGFR transactivation, HB-EGF-CTF nuclear translocation, and cell growth were examined under the condition of ADAM17 knockdown.Result: TGFβ-induced EGFR phosphorylation of which ADAM inhibitors were able to inhibit. TGFβ induced shedding of proHB-EGF allowing HB-EGF-CTF to translocate to the nucleus. ADAM inhibitors blocked this nuclear translocation. TGFβ enhanced gastric cancer cell growth and ADAM inhibitors suppressed this effect. EGFR phosphorylation, HB-EGF-CTF nuclear translocation, and cell growth were suppressed in ADAM17 knockdown cells.Conclusion: HB-EGF-CTF nuclear translocation and EGFR transactivation from proHB-EGF shedding mediated by ADAM17 activated by TGFβ might be an important pathway of gastric cancer cell proliferation by TGFβ. 相似文献
64.
65.
It is well known that soleus muscle of rat atrophies following spaceflight or hindlimb suspension (Ohira et al., 1992). It is, further, reported that the electromyogram (EMG) of soleus muscle disappears immediately in response to unloading by exposure to actual micro-g environment (Kawano et al., 2002; Leterme and Falempin, 1998) and by hindlimb suspension of rats (Alford et al., 1987; Ohira et al., 2000). However, the EMG level is increased gradually to the control level following 7-10 days of continuous hindlimb suspension (Alford et al., 1987; Ohira, 2000), while muscle atrophy is progressing (Winiarski et al., 1987). We previously reported that reduction of the EMG level of rat soleus in response to actual micro-g environment, created by a parabolic flight of a jet airplane, was closely associated with a decrease of the afferent input recorded at the L5 segmental level of spinal cord (Kawano et al., 2002). However, it is still unclear how the EMG level of soleus muscle adapts to unloading condition. The current study was performed to investigate the responses of soleus EMG and both afferent and efferent neurogram at the L5 segmental level of spinal cord to acute (20 seconds) and chronic (14 days) unloading. 相似文献
66.
NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage 总被引:4,自引:0,他引:4
Nakanishi M Ozaki T Yamamoto H Hanamoto T Kikuchi H Furuya K Asaka M Delia D Nakagawara A 《The Journal of biological chemistry》2007,282(31):22993-23004
67.
Yamane K Asano Y Tamaki K Ihn H 《Biochemical and biophysical research communications》2007,352(1):69-77
TGF-beta receptors (TbetaRs) are serine/threonine kinase receptors that bind to TGF-beta and propagate intracellular signaling through Smad proteins. TbetaRs are repressed in some human cancers and expressed at high levels in several fibrotic diseases. We demonstrated that epidermal growth factor (EGF) up-regulates type II TGF-beta receptor (TbetaRII) expression in human dermal fibroblasts. EGF-mediated induction of TbetaRII expression was inhibited by the treatment of fibroblasts with a specific p38 mitogen-activated protein kinase (MAPK) inhibitor, SB203580, whereas MEK inhibitor PD98059 did not block the up-regulation of TbetaRII by EGF. EGF induced the TbetaRII promoter activity, and this induction was significantly blocked by SB203580, but not by PD98059. The overexpression of the dominant negative form of p38alpha or p38beta significantly reduced the induction of TbetaRII promoter activity by EGF. These results indicate that the EGF-mediated induction of TbetaRII expression involves the p38 MAPK signaling pathway. The EGF-mediated induction of TbetaRII expression may participate in a synergistic interplay between EGF and TGF-beta signaling pathway. 相似文献
68.
Sakaki J Kishida M Konishi K Gunji H Toyao A Matsumoto Y Kanazawa T Uchiyama H Fukaya H Mitani H Arai Y Kimura M 《Bioorganic & medicinal chemistry letters》2007,17(17):4804-4807
A series of diazepinylbenzoic acid derivatives were synthesized and tested in the inhibition assay of the transactivation of RXR. Oral treatment of cyano derivatives (16f) was found to show anti-diabetic and anti-obesity effects in KK-A(y) mice. 相似文献
69.
Miki Y Suzuki T Sasano H 《The Journal of steroid biochemistry and molecular biology》2007,106(1-5):97-101
Aromatase is a key enzyme of estrogen production through conversion from serum androgens in estrogen-dependent postmenopausal breast cancer. Aromatase has been reported to be predominantly located in intratumoral stromal cells and adipocytes but not in parenchymal or carcinoma cells in breast cancer tissue. It is, however, true that there have been controversies regarding intratumoral localization of aromatase in human breast carcinoma, especially whether intratumoral production of estrogens through aromatase occurs in parenchymal or stromal cells. Results of several studies suggested that aromatase present in parenchymal carcinoma cells plays more important roles in the growth and invasion of breast carcinomas than that in stromal cells through providing higher levels of estrogens to carcinoma cells. Aromatase inhibitors are increasingly being used in place of tamoxifen after results of various clinical trials demonstrated that aromatase inhibitors are more effective in increasing survival and recurrence of estrogen-dependent breast cancer patients. Therefore, it is important to clarify the estrogen supplying pathway by aromatase inside of breast carcinoma tissues in order to evaluate the possible efficacy of aromatase inhibitor treatment. In this review, the controversies regarding these intratumoral localization patterns in human breast carcinoma will be briefly summarized. 相似文献
70.
Sakaki J Konishi K Kishida M Gunji H Kanazawa T Uchiyama H Fukaya H Mitani H Kimura M 《Bioorganic & medicinal chemistry letters》2007,17(17):4808-4811
Synthesis and structure-activity relationship of RXR antagonists employing a diazepinylbenzoic acid scaffold are described. Of those antagonists, sulfonamide derivatives (6v and 6w) reveal a high antagonistic activity and good pharmacokinetic properties. 相似文献